Prevalence and interpretation of AFF immunostain of DEK::AFF2 fusion-associated papillary squamous cell carcinoma in a retrospective cohort of recurrent sinonasal papillomas
- PMID: 38063896
- DOI: 10.1007/s00428-023-03717-0
Prevalence and interpretation of AFF immunostain of DEK::AFF2 fusion-associated papillary squamous cell carcinoma in a retrospective cohort of recurrent sinonasal papillomas
Abstract
DEK::AFF2 fusion-associated papillary squamous cell carcinoma is a novel entity characterized by its unique translocation and malignant clinical course. In this study, AFF immunohistochemistry (IHC) was performed in recurrent sinonasal papillomas for reviewing the prevalence of undiagnosed DEK::AFF2 carcinomas and to investigate the performance of AFF IHC in diagnosis of DEK::AFF2 carcinomas. Recurrent sinonasal papillomas after surgical excision in a two-decade period were retrieved. Histologic slides were reviewed for features of DEK::AFF2 carcinoma. AFF IHC was performed, and cases with any (> 1%) nuclear positivity were validated by DEK break apart fluorescence in situ hybridization. Totally 43 cases were included, comprising 28 inverted, 6 exophytic, one oncocytic, and 8 non-specified sinonasal papillomas. Five (11.6%) cases exhibited positivity to AFF IHC. Three cases exhibited patchy weak to moderate staining intensity predominantly in a granular cytoplasmic pattern. Two cases exhibited strong and diffuse (> 90%) nuclear staining. Cases showing weak staining were negative for DEK rearrangement, while those with strong staining were positive. Both cases of DEK::AFF2 carcinoma showed aggressive behavior with extensive local invasion and nodal metastasis. Background stromal plasma cells, when present, consistently showed strong and diffuse staining. AFF IHC was further performed in plasmacytoma samples as control and showed strong and diffuse immunoreactivity. A significant minority of recurrent sinonasal papillomas represent DEK::AFF2 carcinomas. Granular, cytoplasmic, or incomplete AFF staining should be considered as negative. In view of the rarity of DEK::AFF2 carcinomas, plasma cells and plasma cell neoplasms are potential for internal and surrogate external controls.
Keywords: DEK::AFF2; Immunohistochemistry; Sinonasal carcinoma.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
DEK::AFF2 Fusion-Associated Squamous Cell Carcinoma: A Case Series with Literature Review on an Emerging and Challenging Entity.Head Neck Pathol. 2024 Sep 23;18(1):86. doi: 10.1007/s12105-024-01690-x. Head Neck Pathol. 2024. PMID: 39312022 Review.
-
DEK-AFF2 fusion-associated papillary squamous cell carcinoma of the sinonasal tract: clinicopathologic characterization of seven cases with deceptively bland morphology.Mod Pathol. 2021 Oct;34(10):1820-1830. doi: 10.1038/s41379-021-00846-2. Epub 2021 Jun 9. Mod Pathol. 2021. PMID: 34108636
-
DEK::AFF2-Associated Papillary Squamous Cell Carcinoma of the Sinonasal Tract: Clinicopathologic Characterization of 9 Cases.Head Neck Pathol. 2025 May 20;19(1):66. doi: 10.1007/s12105-025-01799-7. Head Neck Pathol. 2025. PMID: 40392381
-
DEK-AFF2 Carcinoma of the Sinonasal Region and Skull Base: Detailed Clinicopathologic Characterization of a Distinctive Entity.Am J Surg Pathol. 2021 Dec 1;45(12):1682-1693. doi: 10.1097/PAS.0000000000001741. Am J Surg Pathol. 2021. PMID: 34049316
-
Sinonasal Papillomas-An Up-To-Date Review for Practicing Pathologists.Surg Pathol Clin. 2024 Dec;17(4):561-576. doi: 10.1016/j.path.2024.07.012. Surg Pathol Clin. 2024. PMID: 39489549 Review.
Cited by
-
Adequacy Assessment in Lymph Node Aspirates: An Exploratory Cytomorphologic Analysis of Negative Cervical Node Aspirates of Head and Neck Carcinomas.Acta Cytol. 2024;68(6):497-505. doi: 10.1159/000541050. Epub 2024 Sep 2. Acta Cytol. 2024. PMID: 39222621 Free PMC article.
-
DEK::AFF2 Fusion-Associated Squamous Cell Carcinoma: A Case Series with Literature Review on an Emerging and Challenging Entity.Head Neck Pathol. 2024 Sep 23;18(1):86. doi: 10.1007/s12105-024-01690-x. Head Neck Pathol. 2024. PMID: 39312022 Review.
-
Case Report: "DEK::AFF2 fusion associated sinonasal carcinomas: a novel oncogenic driver and emerging therapeutic strategies".Front Immunol. 2025 Jul 4;16:1611790. doi: 10.3389/fimmu.2025.1611790. eCollection 2025. Front Immunol. 2025. PMID: 40688086 Free PMC article.
-
DEK::AFF2 fusion-associated middle ear non-keratinizing squamous cell carcinoma: A case report.World J Clin Oncol. 2024 Dec 24;15(12):1501-1506. doi: 10.5306/wjco.v15.i12.1501. World J Clin Oncol. 2024. PMID: 39720645 Free PMC article.
-
Primary Laryngeal Squamous Cell Carcinoma with DEK::AFF2 Fusion: The First Case Report.Head Neck Pathol. 2025 Apr 29;19(1):51. doi: 10.1007/s12105-025-01793-z. Head Neck Pathol. 2025. PMID: 40299135 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous